Inogen Announces the Appointment of Andy Reding as Chief Operating Officer
Inogen appointed Andy Reding as its new Chief Operating Officer, a newly created position effective July 6, 2026, to strengthen its global commercial and operational execution. Reding brings over 30 years of experience, having served as Chief Commercial Officer at Viant Medical and VP/GM of Hillrom Respiratory Health.
Key figures
- Rsu grant shares
- 130000
- Vesting schedule years
- 3
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.